Bioequivalency Study of Torsemide Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide
Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose,
2-treatment, 2-period, crossover design.